TMO
Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding):
keluasan pemegang -8.3% ·
aliran saham -1.4% ·
posisi baru bersih -9.1%
— formula
Distribusi luas — penurunan saham dan lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +3 | 260.72M | $131.51B | +5 | −1 |
| Q1 2026 | 190 | +2 | 255.88M | $126.62B | +7 | −6 |
| Q4 2025 | 187 | +3 | 274.75M | $159.19B | +4 | — |
| Q3 2025 | 29 | -1 | 154.46M | $74.90B | +1 | −3 |
| Q2 2025 | 28 | +3 | 123.95M | $50.25B | +3 | — |
| Q1 2025 | 22 | -2 | 60.64M | $30.17B | — | −2 |
| Q4 2024 | 24 | +2 | 61.50M | $31.99B | +2 | — |
| Q3 2024 | 21 | -2 | 44.46M | $27.48B | — | −2 |
| Q2 2024 | 23 | — | 44.78M | $24.75B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasif) | 16.54M | +0.6% | $8.24B | 0.3% | ▲ Add | 2 | SEC ↗ |
| 2 | Capital World Investors ✦ | 11.06M | +17.3% | $5.50B | 0.9% | ▲ Add | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 9.30M | -14.8% | $4.63B | 0.6% | ▼ Trim | 4 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (pasif) | 8.13M | +3.4% | $4.03B | 0.3% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (pasif) | 6.19M | +2.2% | $3.08B | 0.4% | ▲ Add | 4 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 2.72M | +1.9% | $1.35B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 2.32M | -7.5% | $1.15B | 1.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.60M | +11.8% | $794.03M | 0.2% | ▲ Add | 4 | SEC ↗ ×7 |
| 9 | Arrowstreet Capital ✦ | 655.94K | +77.6% | $326.39M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 509.38K | -5.5% | $253.47M | 0.2% | ▼ Trim | 4 | SEC ↗ ×4 |
| 11 | Two Sigma Investments ✦ | 331.26K | -26.7% | $164.84M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 235.37K | -56.7% | $117.12M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 13 | Adage Capital Partners ✦ | 233.45K | -40.2% | $116.17M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 209.26K | -5.4% | $102.36M | 0.1% | ▼ Trim | 4 | SEC ↗ ×6 |
| 15 | Millennium Management ✦ | 188.47K | -45.0% | $93.79M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 155.24K | -14.4% | $77.25M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 120.57K | -64.5% | $60.00M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 18 | Markel Group ✦ | 45.00K | +9.5% | $22.39M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 38.80K | -0.8% | $19.31M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 38.34K | +30.6% | $19.08M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 21 | Dodge & Cox ✦ | 26.11K | -0.1% | $12.99M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | GAMCO Investors ✦ | 3.91K | -5.1% | $1.95M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Third Point | $182.08M | adalah 2.4% |
| Marshall Wace | $171.84M | adalah 0.2% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 24.30K saham, $11,944 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 3.73K lbr · $2.29M
Officer · 400 lbr · $245,752
Officer, Director · 62 lbr · $38,982
Officer, Director · 33 lbr · $20,677
Officer, Director · 101 lbr · $63,166
Officer, Director · 79 lbr · $49,613
Officer, Director · 2.15K lbr · $1.35M
Officer, Director · 1.79K lbr · $1.12M
Officer, Director · 3.01K lbr · $1.89M
Officer, Director · 2.73K lbr · $1.71M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi